{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:51:53Z","timestamp":1787737913121,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.autrev.2022.103100","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:01:15Z","timestamp":1650373275000},"page":"103100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Brandon S.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curry","family":"Koening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Tebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103100_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2022.103100_bb0025","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Limburg Renal Registry. Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103100_bb0030","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103100_bb0035","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3389\/fimmu.2019.02855","article-title":"Personalized medicine in ANCA-associated Vasculitis ANCA specificity as the guide?","volume":"10","author":"Wallace","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103100_bb0040","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.39620","article-title":"HLA-DPB1 as a risk factor for relapse in antineutrophil cytoplasmic antibody\u2013associated vasculitis: a cohort study","volume":"68","author":"Hilhorst","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0055","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of antineutrophil cytoplasmic autoantibody\u2013associated vasculitis in Olmsted County, Minnesota: a twenty-year US population - based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/annrheumdis-2016-209507","article-title":"Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays","volume":"76","author":"Damoiseaux","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103100_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214078","article-title":"Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment","volume":"78","author":"Broeders","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103100_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102716","article-title":"The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis","volume":"20","author":"Guchelaar","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103100_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 international consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103100_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656796","article-title":"ANCA testing in clinical practice: from implementation to quality control and harmonization","volume":"12","author":"Damoiseaux","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103100_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2016.05.031","article-title":"Development of a certified reference material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)","volume":"467","author":"Monogioudi","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2022.103100_bb0090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1515\/cclm-2018-1095","article-title":"Certified reference material against PR3 ANCA IgG autoantibodies. From development to certification","volume":"57","author":"Monogioudi","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/rheumatology\/kes230","article-title":"ANCA vasculitis: to lump or split? Why we should study MPA and GPA separately","volume":"51","author":"Watts","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103100_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0105","first-page":"85","article-title":"STARD 2015: updated reporting guidelines for all diagnostic accuracy studies","volume":"4","author":"Bossuyt","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1373\/49.1.7","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"49","author":"Bossuyt","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2022.103100_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.autrev.2022.103100_bb0120","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.autrev.2022.103100_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2022.103100_bb0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2016.03.010","article-title":"Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)","volume":"15","author":"Csernok","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103100_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcla.20204","article-title":"Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener\u2019s granulomatosis","volume":"22","author":"Feng","year":"2008","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.autrev.2022.103100_bb0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR Project for ANCA Assay Standardization","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103100_bb0150","first-page":"S1","article-title":"A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3","volume":"25","author":"Hellmich","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0155","first-page":"153","article-title":"Detection of anti-neutrophil cytoplasmic antibodies by immunoprecipitation","volume":"18","author":"Lucena-Fernandes","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0160","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archinte.162.13.1509","article-title":"Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?","volume":"162","author":"Mandl","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0165","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1515\/cclm-2013-0308","article-title":"Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener\u2019s)","volume":"51","author":"Radice","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04649.x","article-title":"High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay","volume":"1173","author":"Roggenbuck","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2022.103100_bb0175","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.1780330829","article-title":"Association of autoantibodies to myeloperoxidase with different forms of vasculitis","volume":"33","author":"Tervaert","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1309\/F6L4C48RHFMT4AAU","article-title":"Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease","volume":"129","author":"Trevisin","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2022.103100_bb0185","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1515\/CCLM.2004.236","article-title":"Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection","volume":"42","author":"Villalta","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-1759(97)00154-3","article-title":"Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA)","volume":"208","author":"Wang","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2022.103100_bb0195","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1523-1755.1998.00873.x","article-title":"Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody","volume":"53","author":"Westman","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103100_bb0200","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s10067-019-04736-6","article-title":"Evaluation of 12 different assays for detecting ANCA in Chinese patients with GPA and MPA: a multicenter study in China","volume":"38","author":"Zhang","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic Vasculitides","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary","volume":"33","author":"Fries","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103100_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-123-12-199512150-00005","article-title":"The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis","volume":"123","author":"Rao","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103100_bb0220","first-page":"1584","article-title":"Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies","volume":"28","author":"Choi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0225","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3899\/jrheum.140941","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and proteinase 3-ANCA without immunofluorescent ANCA found by routine clinical testing","volume":"42","author":"Rao","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103100_bb0230","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:25:08Z","timestamp":1761600308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1568997222000702"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103100","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103100"}}